BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 11237742)

  • 1. The F-box protein SKP2 binds to the phosphorylated threonine 380 in cyclin E and regulates ubiquitin-dependent degradation of cyclin E.
    Yeh KH; Kondo T; Zheng J; Tsvetkov LM; Blair J; Zhang H
    Biochem Biophys Res Commun; 2001 Mar; 281(4):884-90. PubMed ID: 11237742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted disruption of Skp2 results in accumulation of cyclin E and p27(Kip1), polyploidy and centrosome overduplication.
    Nakayama K; Nagahama H; Minamishima YA; Matsumoto M; Nakamichi I; Kitagawa K; Shirane M; Tsunematsu R; Tsukiyama T; Ishida N; Kitagawa M; Nakayama K; Hatakeyama S
    EMBO J; 2000 May; 19(9):2069-81. PubMed ID: 10790373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skp2 is oncogenic and overexpressed in human cancers.
    Gstaiger M; Jordan R; Lim M; Catzavelos C; Mestan J; Slingerland J; Krek W
    Proc Natl Acad Sci U S A; 2001 Apr; 98(9):5043-8. PubMed ID: 11309491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skp2-mediated p27(Kip1) degradation during S/G2 phase progression of adipocyte hyperplasia.
    Auld CA; Fernandes KM; Morrison RF
    J Cell Physiol; 2007 Apr; 211(1):101-11. PubMed ID: 17096381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and biological significance of S-phase kinase-associated protein 2 (Skp2) gene expression in gastric carcinoma: modulation of malignant phenotype by Skp2 overexpression, possibly via p27 proteolysis.
    Masuda TA; Inoue H; Sonoda H; Mine S; Yoshikawa Y; Nakayama K; Nakayama K; Mori M
    Cancer Res; 2002 Jul; 62(13):3819-25. PubMed ID: 12097295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PTEN regulates the ubiquitin-dependent degradation of the CDK inhibitor p27(KIP1) through the ubiquitin E3 ligase SCF(SKP2).
    Mamillapalli R; Gavrilova N; Mihaylova VT; Tsvetkov LM; Wu H; Zhang H; Sun H
    Curr Biol; 2001 Feb; 11(4):263-7. PubMed ID: 11250155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Degradation of Tob1 mediated by SCFSkp2-dependent ubiquitination.
    Hiramatsu Y; Kitagawa K; Suzuki T; Uchida C; Hattori T; Kikuchi H; Oda T; Hatakeyama S; Nakayama KI; Yamamoto T; Konno H; Kitagawa M
    Cancer Res; 2006 Sep; 66(17):8477-83. PubMed ID: 16951159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skp2 regulates the antiproliferative function of the tumor suppressor RASSF1A via ubiquitin-mediated degradation at the G1-S transition.
    Song MS; Song SJ; Kim SJ; Nakayama K; Nakayama KI; Lim DS
    Oncogene; 2008 May; 27(22):3176-85. PubMed ID: 18071316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncogenic Ras blocks transforming growth factor-beta-induced cell-cycle arrest by degradation of p27 through a MEK/Erk/SKP2-dependent pathway.
    Schepers H; Wierenga AT; Eggen BJ; Vellenga E
    Exp Hematol; 2005 Jul; 33(7):747-57. PubMed ID: 15963850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of the F-box protein SKP2 induces hyperplasia, dysplasia, and low-grade carcinoma in the mouse prostate.
    Shim EH; Johnson L; Noh HL; Kim YJ; Sun H; Zeiss C; Zhang H
    Cancer Res; 2003 Apr; 63(7):1583-8. PubMed ID: 12670908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High expression of S-phase kinase-interacting protein 2, human F-box protein, correlates with poor prognosis in oral squamous cell carcinomas.
    Kudo Y; Kitajima S; Sato S; Miyauchi M; Ogawa I; Takata T
    Cancer Res; 2001 Oct; 61(19):7044-7. PubMed ID: 11585732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p27(Kip1) ubiquitination and degradation is regulated by the SCF(Skp2) complex through phosphorylated Thr187 in p27.
    Tsvetkov LM; Yeh KH; Lee SJ; Sun H; Zhang H
    Curr Biol; 1999 Jun; 9(12):661-4. PubMed ID: 10375532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The atr protein kinase controls UV-dependent upregulation of p16INK4A through inhibition of Skp2-related polyubiquitination/degradation.
    Al-Khalaf HH; Hendrayani SF; Aboussekhra A
    Mol Cancer Res; 2011 Mar; 9(3):311-9. PubMed ID: 21270107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kip1 meets SKP2: new links in cell-cycle control.
    Amati B; Vlach J
    Nat Cell Biol; 1999 Aug; 1(4):E91-3. PubMed ID: 10559929
    [No Abstract]   [Full Text] [Related]  

  • 15. Differential expression of the F-box proteins Skp2 and Skp2B in breast cancer.
    Radke S; Pirkmaier A; Germain D
    Oncogene; 2005 May; 24(21):3448-58. PubMed ID: 15782142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The F box protein S phase kinase-associated protein 2 regulates adipose mass and adipocyte number in vivo.
    Cooke PS; Holsberger DR; Cimafranca MA; Meling DD; Beals CM; Nakayama K; Nakayama KI; Kiyokawa H
    Obesity (Silver Spring); 2007 Jun; 15(6):1400-8. PubMed ID: 17557977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27.
    Carrano AC; Eytan E; Hershko A; Pagano M
    Nat Cell Biol; 1999 Aug; 1(4):193-9. PubMed ID: 10559916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modification of cullin-1 by ubiquitin-like protein Nedd8 enhances the activity of SCF(skp2) toward p27(kip1).
    Morimoto M; Nishida T; Honda R; Yasuda H
    Biochem Biophys Res Commun; 2000 Apr; 270(3):1093-6. PubMed ID: 10772955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p45SKP2 promotes p27Kip1 degradation and induces S phase in quiescent cells.
    Sutterlüty H; Chatelain E; Marti A; Wirbelauer C; Senften M; Müller U; Krek W
    Nat Cell Biol; 1999 Aug; 1(4):207-14. PubMed ID: 10559918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel route for connexin 43 to inhibit cell proliferation: negative regulation of S-phase kinase-associated protein (Skp 2).
    Zhang YW; Nakayama K; Nakayama K; Morita I
    Cancer Res; 2003 Apr; 63(7):1623-30. PubMed ID: 12670914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.